Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Total raised
$7.5M
2 rounds on record
Latest round
$3M
Convertible Note · May 2025 · 16 mo ago
Team
9
US Form 5500 (plan participants) · Dec 2025 · +50% in a year
Backers
3
Crane Venture Partners, Panache Ventures
The money's age
Due for its next round
16 months since the last round · not hiring
Momentum
0/100
no fresh signals
Tractionpublic signals, read monthly
GitHub stars
14 public repositories
Funding rounds
RoundDateAmountInvestorsSource
Convertible Note May 2025 $3M — SEC Form D
Venture round Aug 2024 $4.5M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity Sandgarden, Inc. sec
Founders and leadersfrom filings, registers and the company's site
Drew BlasExecutive OfficerSEC Form D
Elizabeth ZalmanExecutive Officer, DirectorSEC Form D
Marty McCallExecutive OfficerSEC Form D
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
ThinkCyteSeries C $32M · 2 yr ago • 201-500 employees
ThinkCyte develops single-cell analysis technologies that combine advanced optics, machine learning and biotechnology to support…
Safer, simpler global payments for marketplaces, platforms and banks — compliant by design. Offload risk, unlock revenue, and scale with…
Element BiosciencesSeries D $277M · 2 yr ago • 201-500 employees • 19 roles
Scale without the premium. Introducing VITARI™ Who We Are Our Mission & Vision At Element Biosciences, our mission is to empower the…
RefeynFounded 2018 • 51-200 employees • 11 roles
Discover how Refeyn's mass photometry technologies can rapidly characterize single particles - like proteins and viral vectors - in…
Parallel FluidicsVenture round $3.8M · 3 yr ago • Founded 2020 • 51-200 employees • 1 role
Flow Processing Units (FPUs) combine microfluidics with high-throughput automation to run full workflows on the hardware you already own.
Marama Labs51-200 employees • 3 roles
CloudSpec™ quantifies therapeutic content of nano-formulations, such as RNAin LNPs, in seconds with a unique accurate and precise…

Overview

Sandgarden is an incubator, by design. The most capital-efficient company-making machine out there: one team, one playbook, one product after another.

People

Drew Blas
Executive Officer
Elizabeth Zalman
Executive Officer, Director
Marty McCall
Executive Officer
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
New York United States
HQ
Contact Us
10-50 est. staff
224 W 35th St Ste 500 #2248, New York, NY, 10001-2538
company site

Financials

Total raised
$7.5M
Latest round
Convertible Note
Funding rounds
2
Funding rounds
Round Announced Amount
Convertible Note 2025 $3M Details
Venture - Series Unknown 2024 $4.5M Details